CCDC173 Inhibitors

CCDC173 inhibitors, as a class, include chemicals that interfere with the protein's function by indirectly affecting the cellular processes or signaling pathways in which CCDC173 participates. Although not directly targeting CCDC173, the listed compounds are involved in the regulation of kinase activity or kinase-mediated signaling pathways, which are essential for various cellular functions. Inhibition of these pathways can lead to a change in the phosphorylation state of numerous proteins, potentially including CCDC173, thereby affecting its function.

These inhibitors can act at different levels in cellular signaling processes. For example, staurosporine is known to be a broad-spectrum kinase inhibitor that can affect a wide variety of kinases by competing with ATP for binding to the active site of these enzymes. Wortmannin and LY294002 specifically inhibit PI3K, which is a key component of one of the primary signaling pathways that regulate cell survival and metabolism. This alteration in PI3K activity can cascade down to affect various proteins and processes in the cell.